Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial drug resistance.

Nicholas J White1

  • 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. nickw@tropmedres.ac

The Journal of Clinical Investigation
|April 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Treatment of Plasmodium vivax Malaria.

The American journal of tropical medicine and hygiene·2016
Same author

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.

The New England journal of medicine·2016
Same author

Geographic distribution of amino acid mutations in DHFR and DHPS in Plasmodium vivax isolates from Lao PDR, India and Colombia.

Malaria journal·2016
Same author

The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.

FEMS microbiology reviews·2016
Same author

Reply to Meshnick and Hastings et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2016
Same author

Management of relapsing Plasmodium vivax malaria.

Expert review of anti-infective therapy·2016
Same journal

Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults.

The Journal of clinical investigation·2026
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
See all related articles

Antimalarial drug resistance is a growing threat, but artemisinin-derivative combinations offer a powerful solution. Widespread use of these effective drug combinations can help control and potentially eradicate malaria globally.

Area of Science:

  • Tropical medicine
  • Parasitology
  • Pharmacology

Background:

  • Malaria remains a major global health burden, causing millions of deaths annually, predominantly among children.
  • Emerging resistance to existing antimalarial drugs, except artemisinins, is driving increased mortality, especially in Africa.
  • The development of drug resistance necessitates urgent strategies to combat this parasitic disease.

Purpose of the Study:

  • To highlight the critical threat of antimalarial drug resistance.
  • To emphasize the efficacy and importance of artemisinin-derivative drug combinations.
  • To advocate for the widespread adoption of combination therapies to control malaria.

Main Methods:

  • Review of current antimalarial drug resistance patterns.

Related Experiment Videos

  • Analysis of the effectiveness of artemisinin-derivative combination therapies.
  • Assessment of the potential impact of combination therapies on malaria prevalence.

    • Main Results:

    • Resistance to most antimalarial drug classes is widespread, except for artemisinins.
    • Artemisinin-derivative combinations are highly effective, well-tolerated, and act rapidly.
    • Combination therapy is a key strategy to prevent the emergence of de novo resistance.

    Conclusions:

    • Artemisinin-derivative combination therapies are crucial for overcoming drug resistance.
    • Widespread implementation of these combinations can significantly reduce malaria-related mortality.
    • Combination antimalarial drugs offer a viable strategy to roll back malaria globally.